During ischemia, tidal volume was reduced to 6 mL/kg
& Dewson, G
Attorneys unfamiliar with MDL procedures may miss important deadlines that could result in case dismissal or exclusion from bellwether trial pools
Preclinical Results Highlight Competitive Potential Preclinical data released by SureNano Science suggest that GEP-44 may offer meaningful differentiation compared with earlier-generation GLP therapies, positioning the company for meaningful upside as it progresses through its development phases of the FDA approval pathway
Additionally, thermosensitive nanogels and stimuli-responsive nanocarriers that respond to pH or glucose levels have been proposed for precision-controlled GLP-1 delivery, enabling intelligent drug release based on glycemic fluctuations
Family premiums are up 6%, or $1,408, from last year, similar to the 7% increase recorded in each of the previous two years